$39.85
+0.32 (+0.81%)
Open$40.10
Previous Close$39.53
Day High$40.66
Day Low$39.61
52W High$40.63
52W Low$10.62
Volume—
Avg Volume255.2K
Market Cap1.78B
P/E Ratio—
EPS$-0.82
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+12.8% upside
Current
$39.85
$39.85
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 46.42M | 203.59M | 209.55M |
| Net Income | -49,381,664 | 62.98M | 65.23M |
| Profit Margin | -106.4% | 30.9% | 31.1% |
| EBITDA | -67,378,876 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |